Annekathrin Haberland
5PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jun 02, 2021
Aptamer BC 007's Affinity to Specific and Less-Specific Anti-SARS-CoV-2 Neutralizing Antibodies.Annekathrin Haberland, Oxana Krylova, Heike Nikolenko
|Mar 31, 2020
A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects.Niels-Peter Becker, Annekathrin Haberland, Katrin Wenzel
|Mar 19, 2019
Activation of T Lymphocytes as a Novel Mechanism in Beta1-Adrenergic Receptor Autoantibody-Induced Cardiac Remodeling-Additional Information About TLR9 Involvement.Annekathrin Haberland, Johannes Müller, Katrin Wenzel
|Jan 24, 2019
In-Vivo Degradation of DNA-Based Therapeutic BC 007 in Humans.Hanna Davideit, Susanne Becker, Johannes Müller
|Feb 10, 2018
Difference between beta1-adrenoceptor autoantibodies of human and animal origin-Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology.Katrin Wenzel, Sarah Schulze-Rothe, Johannes Müller
Pageof 1
